Akebia Therapeutics akebia.com


Public list: BIO 2016 (619) Pharma Startups (4500)

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once daily, oral HIF2 stabilizing agent (HIF-PH inhibitor) in phase 2 clinical trials for chronic anemia. Akebia also has a platform of HPTP├č inhibitors / Angiopoietin 2 modulators which have demonstrated preclinical proof of concept in vascular leak, angiogenesis and as anti-metastatic agents. Akebia Thera...Show all

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once daily, oral HIF2 stabilizing agent (HIF-PH inhibitor) ...Show all

Company (IPO / Went public)

Phone: 513-985-1920

Fax:

9987 Carver Road
Suite 420
Cincinnati, 45242
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Akebia Therapeutics $195.3M Mar 21, 2014
Humanetics Corporation $0.6M Aug 10, 2016
Affinium Pharmaceuticals $44.9M Sep 12, 2013
See all 33 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Akebia Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Competitors

Company Status Description Investors
See all 33 competitors